Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon Cancers.

Cancers (Basel) · 2021 · PMC8656858 · PMID 34885067

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, we found a tendency for poorer prognosis when the RASSF2 promoter was hypermethylated, whereas the hypermethylation of LATS2 promoter showed a trend for a better prognosis, but not significantly (data not shown).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.